Susan A Charman Selected Research

MMV390048

1/2018	UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria.
1/2017	Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan A Charman Research Topics

Disease

37	Malaria 04/2022 - 08/2004
12	Neoplasms (Cancer) 12/2021 - 08/2009
7	Chagas Disease (American Trypanosomiasis) 12/2020 - 05/2012
7	Infections 01/2019 - 05/2014
5	Parasitemia 01/2021 - 09/2012
3	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2017 - 07/2006
2	Drug-Related Side Effects and Adverse Reactions 12/2021 - 09/2015
2	Parkinson Disease (Parkinson's Disease) 09/2021 - 01/2017
2	Autoimmune Diseases (Autoimmune Disease) 08/2020 - 06/2014
1	Hypoxia (Hypoxemia) 01/2022
1	COVID-19 01/2022
1	Tuberculosis (Tuberculoses) 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Visceral Leishmaniasis (Kala Azar) 12/2020
1	Neglected Diseases 10/2020
1	Schistosomiasis (Bilharziasis) 10/2020
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Trypanosomiasis 11/2016
1	Persistent Infection 10/2016
1	Body Weight (Weight, Body) 09/2015

Drug/Important Bio-Agent (IBA)

28	Pharmaceutical PreparationsIBA 04/2022 - 04/2010
17	Antimalarials (Antimalarial Agents)IBA 11/2021 - 08/2004
8	EnzymesIBA 01/2020 - 06/2012
6	1,2,4-trioxaneIBA 01/2021 - 03/2011
6	Dihydroorotate DehydrogenaseIBA 01/2021 - 06/2014
6	Biological ProductsIBA 12/2019 - 02/2010
5	DSM265IBA 01/2021 - 07/2015
5	artemisinin (artemisinine)IBA 01/2019 - 08/2004
4	Carbonic Anhydrases (Carbonic Anhydrase)IBA 12/2013 - 10/2009
3	Heme (Haem)IBA 11/2021 - 08/2004
3	IronIBA 09/2021 - 01/2017
3	pyrimidineIBA 01/2020 - 07/2015
3	PeroxidesIBA 01/2020 - 07/2006
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2015
3	benzonidazole (benznidazole)IBA 10/2016 - 09/2012
3	ProdrugsIBA 09/2015 - 09/2011
3	SulfonamidesIBA 12/2013 - 10/2009
3	IsoenzymesIBA 06/2012 - 10/2009
2	alpha-SynucleinIBA 09/2021 - 01/2017
2	8-hydroxyquinazolin-4(3H)-oneIBA 09/2021 - 01/2017
2	ArtesunateIBA 01/2019 - 08/2004
2	MMV390048IBA 01/2018 - 01/2017
2	alpha-aminopyridineIBA 01/2018 - 01/2017
2	NifurtimoxIBA 10/2016 - 01/2015
2	SulfonesIBA 10/2016 - 08/2014
2	fexinidazoleIBA 10/2016 - 08/2014
2	6- Chloro- 7- methoxy- 2- methyl- 3- (4- (4- (trifluoromethoxy)phenoxy)phenyl)quinolin- 4(1H)- oneIBA 09/2015 - 03/2013
2	QuinolonesIBA 05/2014 - 09/2012
2	fenarimolIBA 12/2013 - 05/2012
2	SterolsIBA 11/2013 - 09/2012
2	Tubulin ModulatorsIBA 09/2011 - 08/2009
2	CYT997IBA 11/2009 - 08/2009
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Isoniazid (Ftivazide)FDA LinkGeneric 12/2021
1	Complement System Proteins (Complement)IBA 12/2021
1	taxaneIBA 12/2021
1	DiureticsIBA 01/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2021
1	TriazinesIBA 01/2021
1	5-(N,N-hexamethylene)amilorideIBA 01/2021
1	Amiloride (Midamor)FDA LinkGeneric 01/2021
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2021
1	pretomanidIBA 12/2020
1	NitroimidazolesIBA 12/2020
1	Praziquantel (Biltricide)FDA Link 10/2020
1	AntigensIBA 08/2020
1	artefenomelIBA 01/2020
1	arterolaneIBA 01/2020
1	Lysine AcetyltransferasesIBA 01/2020
1	PyrrolesIBA 01/2020
1	CarbonIBA 12/2019
1	ZincIBA 01/2019
1	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2019
1	AminopeptidasesIBA 01/2019
1	proguanil drug combination atovaquone (malarone)FDA Link 11/2018
1	2- Fluoro- N'- (3- fluoro- 5- (pyridin- 2- yl)benzoyl)benzenesulfonohydrazideIBA 01/2018
1	1-Phosphatidylinositol 4-Kinase (1 Phosphatidylinositol 4 Kinase)IBA 01/2018
1	2-(phenylsulfonyl)hydrazide 4-fluoro-5-methyl- (1,1'-Biphenyl)-3-carboxylic acidIBA 01/2018
1	LigandsIBA 01/2017
1	2-aminopyrazineIBA 11/2016
1	Mefloquine (Lariam)FDA LinkGeneric 11/2015
1	Drug CombinationsIBA 07/2015
1	Guanosine Triphosphate (GTP)IBA 01/2015
1	Peptide Elongation Factor 2 (EF-2)IBA 01/2015
1	DDD107498IBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	SJ733IBA 12/2014
1	sulfoxideIBA 08/2014
1	Atovaquone (Mepron)FDA Link 05/2014
1	Chloroquine (Aralen)FDA LinkGeneric 05/2014
1	thiaplakortone AIBA 02/2014

Therapy/Procedure

7	Therapeutics 12/2021 - 06/2011
3	Drug Therapy (Chemotherapy) 12/2021 - 08/2004
3	Oral Administration 01/2019 - 08/2014
1	Duration of Therapy 10/2016